Clinical trial
A Phase II Study of Bortezomib in Combination With Dexamethasone in Patients With Relapsed Hodgkin's Lymphoma
NCT00148018 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Bortezomib in Combination With Dexamethasone in Patients With Relapsed Hodgkin's Lymphoma
- Lead sponsor
- University of Cologne
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2005
- Completion date
- Not reported
- Enrollment
- 37
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.